capsule experience - MG Lorenzatto

More documents

Recommendations

Info

98 Chapter 8 M2A ® Figure 8.7b Diffuse bleeding was observed during <strong>capsule</strong> endoscopy procedure, same case. M2A ® Figure 8.7d Note lymphangiectasia, same case. M2A ® Malabsorption Figure 8.7c Distally in ileum villi reappear slowly, same case. Figure 8.7e Histologic view of atrophic villi. Note the hypertrophic crypts, the “normal¢ basal membrane and the dense lymphoid cell infiltrate. (Reticulin stain, x50).
Chapter 8 Figure 8.7f Higher magnification. Hyperplastic crypts and dense lymphoid infiltrate (Reticulin, x500), same case. Figure 8.7h Sprue-like picture with hyperplastic crypts, lymphoid cellular infiltrate (PAS stain, x500), same case. Malabsorption Figure 8.7g Microscopic overview showing villous atrophy, hypertrophic crypts and lymphoid infiltrate (PAS stain, x100), same case. Figure 8.7i Sprue-like picture with hyperplastic crypts, lymphoid cellular infiltrate in lamina propria (PAS stain, x500), same case. 99
Page 1 and 2:
Atlas of Capsule Endoscopy Editors:
Page 3 and 4:
Atlas of Capsule Endoscopy Marisa H
Page 5 and 6:
Acknowledgments We would like to th
Page 7 and 8:
Table of contents Development of th
Page 9 and 10:
4 Development of the Swallowable Vi
Page 11 and 12:
Notes From the Inventor Gavriel J.
Page 13 and 14:
10 Chapter 1 THE OPTICAL DOME The o
Page 15 and 16:
12 Chapter 1 c. Conscious sedation
Page 17 and 18:
16 Chapter 2 Typical timing of a ca
Page 19 and 20:
18 Chapter 2 Figure 1. Intializing
Page 21 and 22:
20 Chapter 2 Figure 5. Time Capsule
Page 23 and 24:
24 Chapter 3 becomes very obvious.
Page 25 and 26:
26 Chapter 3 M2A ® M2A ® Figure 3
Page 27 and 28:
28 Chapter 3 M2A ® Figure 3.5b Nor
Page 29 and 30:
30 Chapter 3 M2A ® M2A ® Figure 3
Page 31 and 32:
Chapter 4 Inflammatory Diseases of
Page 33 and 34:
Chapter 4 6 Sayek I, Aran O, Uzunal
Page 35 and 36:
Chapter 4 M2A ® M2A ® Figure 4.4a
Page 37 and 38:
Chapter 4 M2A ® Figure 4.5f Pseudo
Page 39 and 40: Chapter 4 M2A ® Figure 4.6f Extens
Page 41 and 42: Chapter 4 M2A ® M2A ® Figure 4.10
Page 43 and 44: Chapter 4 M2A ® Figure 4.15a Jejun
Page 45 and 46: 48 Chapter 5 with small bowel tumor
Page 47 and 48: 50 Chapter 5 M2A ® Figure 5.4a Lar
Page 49 and 50: 52 Chapter 5 M2A ® Figure 5.7b Sam
Page 51 and 52: 54 Chapter 5 M2A ® Figure 5.11a A
Page 53 and 54: 56 Chapter 5 Figure 5.12c Biopsy of
Page 55 and 56: 58 Chapter 5 M2A ® Figure 5.15a Ad
Page 57 and 58: 60 Chapter 5 M2A ® Figure 5.18a No
Page 59 and 60: Chapter 6 Iatrogenic Diseases David
Page 61 and 62: Chapter 6 Iatrogenic Diseases M2A
Page 67 and 68: Chapter 7 Vascular Abnormalities Ma
Page 69 and 70: Chapter 7 References and Suggested
Page 71 and 72: Chapter 7 M2A ® Figure 7.2 74 year
Page 73 and 74: Chapter 7 M2A ® Figure 7.8a Small
Page 75 and 76: Chapter 8 Malabsorption Gerard Gay,
Page 77 and 78: Chapter 8 References and Suggested
Page 79 and 80: Chapter 8 Endoscopic management of
Page 81 and 82: Chapter 8 M2A ® M2A ® Figure 8.1e
Page 83 and 84: Chapter 8 Figure 8.3a Enteroscopy p
Page 85 and 86: Chapter 8 M2A ® M2A ® Figure 8.3i
Page 87 and 88: Chapter 8 M2A ® Figure 8.4a Celiac
Page 89: Chapter 8 Figure 8.6e Histological
Page 93 and 94: Chapter 8 M2A ® Figure 8.9a 38 yea
Page 95 and 96: 104 Chapter 9 Our preliminary data
Page 97 and 98: 106 Chapter 9 M2A ® M2A ® Figure
Page 99 and 100: 108 Chapter 9 M2A ® Figure 9.4a 11
Page 101 and 102: 112 Chapter 10 transplant. Indicati
Page 103 and 104: 114 Chapter 10 M2A ® Figure 10.2b
Page 105 and 106: 116 Chapter 10 M2A ® Figure 10.4c
Page 107 and 108: 120 Chapter 11 CONCLUSION During th
Page 109 and 110: 122 Chapter 11 M2A ® Figure 11.4a
Page 111 and 112: Contributors Carla Abbiati, M.D. Un
Page 113 and 114: 128 Contributors (continued) Sandor
Page 115 and 116: 130 Contributors (continued) Ana Sa
show all

capsule experience - MG Lorenzatto

Create successful ePaper yourself

Delete template?

Save as template?